https://www.ilcoala.it/en https://www.ilcoala.it https://www.ilcoala.it/en/chi-siamo https://www.ilcoala.it/chi-siamo https://www.ilcoala.it/en/collaborazioni-e-ricerca https://www.ilcoala.it/collaborazioni-e-ricerca https://www.ilcoala.it/en/contatti https://www.ilcoala.it/contatti https://www.ilcoala.it/en/le-malattie https://www.ilcoala.it/le-malattie https://www.ilcoala.it/en/news https://www.ilcoala.it/news https://www.ilcoala.it/en/prenota-la-tua-visita https://www.ilcoala.it/prenota-la-tua-visita https://www.ilcoala.it/en/privacy-policy https://www.ilcoala.it/privacy-policy https://www.ilcoala.it/en/search https://www.ilcoala.it/search https://www.ilcoala.it/en/servizi https://www.ilcoala.it/servizi https://www.ilcoala.it/en/dona https://www.ilcoala.it/dona https://www.ilcoala.it/new/1a-tavola-rotonda-nazionale-col4a1-a2 https://www.ilcoala.it/en/new/1a-tavola-rotonda-nazionale-col4a1-a2 https://www.ilcoala.it/new/allan-herndon-dudley-syndrome https://www.ilcoala.it/en/new/allan-herndon-dudley-syndrome https://www.ilcoala.it/new/caratterizzazione-fenotipica-del-deficit-del-trasportatore-cerebrale-degli-ormoni-tiroidei-mct8-sindrome-di-allan-hernon-dudley-ahds https://www.ilcoala.it/en/new/caratterizzazione-fenotipica-del-deficit-del-trasportatore-cerebrale-degli-ormoni-tiroidei-mct8-sindrome-di-allan-hernon-dudley-ahds https://www.ilcoala.it/new/cgas-mediated-induction-of-type-i-interferon-due-to-inborn-errors-of-histone-pre-mrna-processing https://www.ilcoala.it/en/new/cgas-mediated-induction-of-type-i-interferon-due-to-inborn-errors-of-histone-pre-mrna-processing https://www.ilcoala.it/new/clinical-spectrum-of-polr3-related-leukodystrophy-caused-by-biallelic-polr1c-pathogenic-variants https://www.ilcoala.it/en/new/clinical-spectrum-of-polr3-related-leukodystrophy-caused-by-biallelic-polr1c-pathogenic-variants https://www.ilcoala.it/new/come-identificare-le-calcificazioni-cerebrali-nei-pazienti-in-eta-peditrica-con-malattia-neurologica-tc-rmn-o-entrambe https://www.ilcoala.it/en/new/come-identificare-le-calcificazioni-cerebrali-nei-pazienti-in-eta-peditrica-con-malattia-neurologica-tc-rmn-o-entrambe https://www.ilcoala.it/new/conferenza-annuale-delle-famiglie https://www.ilcoala.it/en/new/conferenza-annuale-delle-famiglie https://www.ilcoala.it/new/convegno-nazionale-delle-famiglie https://www.ilcoala.it/en/new/convegno-nazionale-delle-famiglie https://www.ilcoala.it/new/dallo-screening-neonatale-alla-terapia-per-le-leucodistrofie https://www.ilcoala.it/en/new/dallo-screening-neonatale-alla-terapia-per-le-leucodistrofie https://www.ilcoala.it/new/de-novo-eif2ak1-and-eif2ak2-variants-are-associated-with-developmental-delay-leukoencephalopathy-and-neurologic-decompensation https://www.ilcoala.it/en/new/de-novo-eif2ak1-and-eif2ak2-variants-are-associated-with-developmental-delay-leukoencephalopathy-and-neurologic-decompensation https://www.ilcoala.it/new/disease-characteristics-of-mct8-deficiency-an-international-retrospective-multicentre-cohort-study https://www.ilcoala.it/en/new/disease-characteristics-of-mct8-deficiency-an-international-retrospective-multicentre-cohort-study https://www.ilcoala.it/new/disordini-del-movimento-nel-deficit-di-mct8-sindrome-di-allan-hernon-dudley https://www.ilcoala.it/en/new/disordini-del-movimento-nel-deficit-di-mct8-sindrome-di-allan-hernon-dudley https://www.ilcoala.it/new/ela-families-scientists-meeting-2023 https://www.ilcoala.it/en/new/ela-families-scientists-meeting-2023 https://www.ilcoala.it/new/endocrine-and-growth-abnormalities-in-4h-leukodystrophy-caused-by-variants-in-polr3a-polr3b-and-polr1c https://www.ilcoala.it/en/new/endocrine-and-growth-abnormalities-in-4h-leukodystrophy-caused-by-variants-in-polr3a-polr3b-and-polr1c https://www.ilcoala.it/new/episodi-parossistici-e-coinvolgimento-midollare-nella-ipomielinizzazione-transitoria-ad-esordio-infantile-associata-al-gene-tmem63a https://www.ilcoala.it/en/new/episodi-parossistici-e-coinvolgimento-midollare-nella-ipomielinizzazione-transitoria-ad-esordio-infantile-associata-al-gene-tmem63a https://www.ilcoala.it/new/establishing-patient-centered-outcomes-for-mct8-deficiency-stakeholder-engagement-and-systematic-literature-review https://www.ilcoala.it/en/new/establishing-patient-centered-outcomes-for-mct8-deficiency-stakeholder-engagement-and-systematic-literature-review https://www.ilcoala.it/new/genitori-di-bambini-speciali-e-nutrizione-artificiale-a-tu-per-tu-con-gli-esperti https://www.ilcoala.it/en/new/genitori-di-bambini-speciali-e-nutrizione-artificiale-a-tu-per-tu-con-gli-esperti https://www.ilcoala.it/new/hypomyelination-with-atrophy-of-basal-ganglia-and-cerebellum-h-abc-natural-history-study https://www.ilcoala.it/en/new/hypomyelination-with-atrophy-of-basal-ganglia-and-cerebellum-h-abc-natural-history-study https://www.ilcoala.it/new/ii-convegno-nazionale-famiglie-ela-italia https://www.ilcoala.it/en/new/ii-convegno-nazionale-famiglie-ela-italia https://www.ilcoala.it/new/l-evoluzione-della-malattia-di-alexander-nel-tempo-dati-da-una-coorte-italiana-di-pazienti-ad-esordio-pediatrico https://www.ilcoala.it/en/new/l-evoluzione-della-malattia-di-alexander-nel-tempo-dati-da-una-coorte-italiana-di-pazienti-ad-esordio-pediatrico https://www.ilcoala.it/new/late-onset-aicardi-goutieres-syndrome-a-characterization-of-presenting-clinical-features https://www.ilcoala.it/en/new/late-onset-aicardi-goutieres-syndrome-a-characterization-of-presenting-clinical-features https://www.ilcoala.it/new/lepilessia-nella-sindrome-di-aicardi-goutieres-caratteristiche-elettriche-cliniche-e-radiologiche https://www.ilcoala.it/en/new/lepilessia-nella-sindrome-di-aicardi-goutieres-caratteristiche-elettriche-cliniche-e-radiologiche https://www.ilcoala.it/new/leucodistrofie-e-leucoencefalopatie-genetiche-creazione-di-un-database-clinico-e-radiologico https://www.ilcoala.it/en/new/leucodistrofie-e-leucoencefalopatie-genetiche-creazione-di-un-database-clinico-e-radiologico https://www.ilcoala.it/new/leucodistrofie-e-leucoencefalopatie-genetiche-nuovi-orizzonti-terapeutici https://www.ilcoala.it/en/new/leucodistrofie-e-leucoencefalopatie-genetiche-nuovi-orizzonti-terapeutici https://www.ilcoala.it/new/malattie-di-alexander-webinar-per-le-famiglie https://www.ilcoala.it/en/new/malattie-di-alexander-webinar-per-le-famiglie https://www.ilcoala.it/new/natale-con-gli-autori-e-obm-insieme-per-il-coala https://www.ilcoala.it/en/new/natale-con-gli-autori-e-obm-insieme-per-il-coala https://www.ilcoala.it/new/novel-and-emerging-treatments-for-aicardi-goutieres-syndrome https://www.ilcoala.it/en/new/novel-and-emerging-treatments-for-aicardi-goutieres-syndrome https://www.ilcoala.it/new/novel-mutations-in-slc16a2-associated-with-a-less-severe-phenotype-of-mct8-deficiency https://www.ilcoala.it/en/new/novel-mutations-in-slc16a2-associated-with-a-less-severe-phenotype-of-mct8-deficiency https://www.ilcoala.it/new/pediatric-movement-disorders-series-thyroid-and-movement-disorders https://www.ilcoala.it/en/new/pediatric-movement-disorders-series-thyroid-and-movement-disorders https://www.ilcoala.it/new/pelizaeus-merzbacher-disease-pmd-natural-history-study https://www.ilcoala.it/en/new/pelizaeus-merzbacher-disease-pmd-natural-history-study https://www.ilcoala.it/new/phenotypic-spectrum-of-short-chain-enoyl-coa-hydratase-1-echs1-deficiency https://www.ilcoala.it/en/new/phenotypic-spectrum-of-short-chain-enoyl-coa-hydratase-1-echs1-deficiency https://www.ilcoala.it/new/primo-congresso-nazionale-sulle-lecuodistrofia-in-eta-pediatrica-dalla-diagnosi-al-trattamento https://www.ilcoala.it/en/new/primo-congresso-nazionale-sulle-lecuodistrofia-in-eta-pediatrica-dalla-diagnosi-al-trattamento https://www.ilcoala.it/new/ruxolitinib-nella-sindrome-di-aicardi-goutieres https://www.ilcoala.it/en/new/ruxolitinib-nella-sindrome-di-aicardi-goutieres https://www.ilcoala.it/new/screening-neonatale-per-ladrenoleucodistrofia-x-linked-in-italia-algoritmo-diagnostico-e-monitoraggio-della-malattia https://www.ilcoala.it/en/new/screening-neonatale-per-ladrenoleucodistrofia-x-linked-in-italia-algoritmo-diagnostico-e-monitoraggio-della-malattia https://www.ilcoala.it/new/studio-di-fase-1-3-in-doppio-cieco-randomizzato-controllato-con-placebo-per-valutare-lefficacia-la-sicurezza-la-farmacocinetica-e-la-farmacodinamica-di-ion373-somministrato-per-via-intratecale-in-pazienti-affetti-da-malattia-di-alexander https://www.ilcoala.it/en/new/studio-di-fase-1-3-in-doppio-cieco-randomizzato-controllato-con-placebo-per-valutare-lefficacia-la-sicurezza-la-farmacocinetica-e-la-farmacodinamica-di-ion373-somministrato-per-via-intratecale-in-pazienti-affetti-da-malattia-di-alexander https://www.ilcoala.it/new/triac-trial-ii https://www.ilcoala.it/en/new/triac-trial-ii https://www.ilcoala.it/new/vaia-y-mura-e-tonduti-d https://www.ilcoala.it/en/new/vaia-y-mura-e-tonduti-d https://www.ilcoala.it/new/webinar-le-leucodistrofie-ipomielinizzanti https://www.ilcoala.it/en/new/webinar-le-leucodistrofie-ipomielinizzanti https://www.ilcoala.it/articoli/adrenoleucodistrofia-legata-allx-al-via-lo-screening-per-i-neonati-lombardi https://www.ilcoala.it/en/articoli/adrenoleucodistrofia-legata-allx-al-via-lo-screening-per-i-neonati-lombardi https://www.ilcoala.it/articoli/alexander-disease-research-update https://www.ilcoala.it/en/articoli/alexander-disease-research-update https://www.ilcoala.it/articoli/la-borsa-magica-di-nini https://www.ilcoala.it/en/articoli/la-borsa-magica-di-nini https://www.ilcoala.it/articoli/lo-screening-neonatale https://www.ilcoala.it/en/articoli/lo-screening-neonatale https://www.ilcoala.it/articoli/nasce-a-milano-il-centro-ospedaliero-coala https://www.ilcoala.it/en/articoli/nasce-a-milano-il-centro-ospedaliero-coala https://www.ilcoala.it/articoli/parlano-di-noi-omar-osservatorio-malattie-rare https://www.ilcoala.it/en/articoli/parlano-di-noi-omar-osservatorio-malattie-rare https://www.ilcoala.it/articoli/primo-congresso-nazionale-sulle-leucodistrofie-in-eta-pediatrica https://www.ilcoala.it/en/articoli/primo-congresso-nazionale-sulle-leucodistrofie-in-eta-pediatrica https://www.ilcoala.it/articoli/sindrome-col4a1-a2-in-preparazione-le-prime-linee-guida-sulla-gestione-della-patologia https://www.ilcoala.it/en/articoli/sindrome-col4a1-a2-in-preparazione-le-prime-linee-guida-sulla-gestione-della-patologia